How long does one box of Gilitinib last?

Gilitinib (Gilteritinib) is a targeted therapy drug used to treat certain types of leukemia. The content of each box and the duration of use are important factors that patients and doctors need to consider. Typically, giritinib is supplied in tablets of 120 milligrams (mg), which are taken orally once daily, so the number of tablets contained in a box of giritinib will determine the duration of its use.

The dosage regimen of giritinib may be adjusted based on the patient's specific conditions. Doctors may determine appropriate dosage and treatment based on factors such as the severity of the patient's condition, weight, age, and individual tolerance of the drug. Sometimes, treatment may take longer, or the dosage may vary.

In addition, while taking giritinib, patients should strictly follow the doctor's instructions and are not allowed to change the dosage or stop taking the medicine on their own. At the same time, if any discomfort or side effects occur during medication, you should report it to your doctor immediately so that the treatment plan can be adjusted in a timely manner.

Giritinib works by inhibitingFLT3kinase activity. FLT3kinase plays an important role in regulating cell proliferation and survival in normal cells, but in leukemia cells, especially those cells carrying FLT3 mutations, its activity is abnormally enhanced. The function of giritinib is to selectively inhibit the activity of FLT3 kinase, thereby preventing the proliferation and survival of leukemia cells, helping to control the disease and prolong the survival time of patients.

In general, giritinib, as a targeted therapy, provides an effective treatment option for some leukemia patients, but patients need to be closely monitored during use and follow the doctor's guidance for treatment to ensure optimal efficacy and safety.